Biotechnology Research-Export Licensing In Russia.

1. Introduction

Biotechnology Research-Export Licensing in Russia refers to the legal framework governing the export of biological materials, microorganisms, genetically modified organisms (GMOs), genetic elements, laboratory equipment, biotechnology software, scientific technology and research-related information from Russia to foreign countries.

The Russian regulatory system seeks to achieve two objectives:

Scientific and commercial development: Allow Russian universities, biotechnology companies, research institutes and pharmaceutical organisations to participate in international scientific collaboration.

National security and biological safety: Prevent sensitive biological materials, pathogens, toxins, genetic technologies and dual-use scientific knowledge from being transferred for prohibited military, terrorist or other harmful purposes.

Russia does not operate one universal biotechnology export licence. Instead, several legal regimes apply depending on the nature of the material, its intended use, the recipient, and its potential dual-use characteristics.

The principal legislation includes:

Federal Law No. 183-FZ of 18 July 1999, On Export Control.

Government Resolution No. 1287 of 16 July 2022.

Government Resolution No. 572 of 2 April 2022.

Government Resolution No. 517 of 15 August 2005.

Federal Law No. 52-FZ of 30 March 1999, On the Sanitary and Epidemiological Welfare of the Population.

Applicable Eurasian Economic Union customs and non-tariff regulation rules.

These laws establish the licensing, identification, documentation, inspection and enforcement framework for biotechnology exports.

CIS Legislation+3

 

2. Federal Law No. 183-FZ: The Principal Export-Control Legislation

Federal Law No. 183-FZ is the foundation of Russia's export-control system.

It regulates international transactions involving goods, technologies, information, services and intellectual property that could contribute to:

The development of weapons of mass destruction.

The development of biological weapons.

The production of military equipment.

The delivery systems for prohibited weapons.

Terrorist activities.

Application to biotechnology research

The legislation is particularly relevant when Russian biotechnology organisations intend to export:

Controlled pathogenic microorganisms.

Biological toxins.

Genetically modified microorganisms.

Specialised biological production equipment.

Genetic-engineering technologies.

Technical information necessary to develop or manufacture controlled biological products.

Article 19 establishes licensing requirements for foreign transfers of controlled goods and technologies, including transfers of intellectual property rights.

The licensing authority is the specially authorised federal executive body responsible for export control, principally the Federal Service for Technical and Export Control (FSTEC).

Article 24 places responsibility for identifying controlled goods and technologies and obtaining the necessary licences or permissions on the Russian participant in foreign economic activity.

CIS Legislation+2

 

3. Government Resolution No. 1287 of 2022: Biological Export-Control List

Key biotechnology regulation

Government Resolution No. 1287 of 16 July 2022 approves the list of microorganisms, toxins, equipment and technologies subject to export control.

The list is especially important because it identifies biological materials and technologies that require enhanced regulatory scrutiny.

It contains seven principal sections:

SectionRegulated subject
1Microorganisms pathogenic to humans and toxins
2Microorganisms pathogenic to animals
3Microorganisms pathogenic to plants
4Genetically modified microorganisms and genetic elements
5Equipment
6Technologies
7Software

A. Pathogenic microorganisms

Certain viruses, bacteria and other biological agents are specifically identified in the list.

Their export may require a licence even when the exporter describes the transaction as a scientific research collaboration.

B. Genetically modified microorganisms

The regulation also addresses genetically modified microorganisms and genetic elements.

This is significant for research involving genetic engineering, synthetic biology and advanced biotechnology.

C. Biotechnology equipment

Specialised equipment can also be controlled where its technical characteristics correspond to the list.

D. Technology and software

Export control is not restricted to physical biological samples. Certain technical information, software and specialised knowledge can also fall within the regime.

Important research exception: Resolution No. 1287 excludes publicly available information, fundamental scientific research and information necessary for preparing a patent application from its export-control coverage, subject to the precise terms of the list.

Consequently, not every scientific publication, university research result or biotechnology-related data transfer requires an export licence.

Consultant Plus+2

 

4. Government Resolution No. 572 of 2022: Export of Pathogenic Microorganisms and Viruses

Government Resolution No. 572 of 2 April 2022 establishes rules for importing and exporting pathogenic microorganisms and viruses.

It is particularly relevant to:

University microbiology laboratories.

Infectious-disease research institutions.

Vaccine research organisations.

Pharmaceutical laboratories.

Biological safety research centres.

The rules cover specified research purposes, including fundamental and applied research in biological safety.

However, an important distinction must be maintained.

Pathogens already controlled under Resolution No. 1287 are excluded from the ordinary Resolution No. 572 procedure. They must instead be examined under the export-control framework.

The rules were amended by Government Resolution No. 626 of 18 May 2024, effective from 1 September 2024.

This distinction prevents exporters from treating ordinary biological-material permissions as substitutes for dual-use export-control licences.

Consultant Plus+1

 

5. Licensing Authorities and Their Responsibilities

Different government authorities may become involved depending on the nature of the exported material.

AuthorityPrincipal responsibility
FSTECExport control and controlled biotechnology transfers
Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor)Relevant sanitary and epidemiological permissions
Federal Service for Veterinary and Phytosanitary Surveillance (Rosselkhoznadzor)Relevant veterinary, plant-health and quarantine controls
Federal Customs ServiceCustoms declarations and enforcement of export restrictions
Russian Export Control CommissionDecisions on specified enhanced-control matters

The exporter must identify which authority has jurisdiction rather than assume that approval from one agency satisfies every legal requirement.

6. Procedure for Obtaining a Biotechnology Export Licence

Russian biotechnology exporters should follow a structured compliance process.

Identification of the biological material

Determine whether the proposed export involves microorganisms, human biological samples, genetic material, toxins, laboratory equipment, software or technical information.

Classification under export-control lists

Compare the material and its technical characteristics against the applicable controlled-goods lists, particularly Resolution No. 1287 and other relevant dual-use lists.

Determination of the intended purpose

Establish whether the export is for fundamental research, clinical research, commercial biotechnology, medical diagnosis, industrial production or another purpose.

Identification of the foreign recipient

Examine the foreign university, laboratory, pharmaceutical company or research institution receiving the material. Establish whether it can transfer the material to third parties.

Preparation of licensing documents

Prepare the relevant technical descriptions, research agreements, contracts, end-user information, shipping documents and supporting regulatory permissions.

Application to the competent authority

Apply to FSTEC for the relevant export-control licence or permission. Additional permissions may be necessary under sanitary, medical, veterinary or quarantine legislation.

Customs clearance

Submit the correct customs declaration and the required licences, permissions and supporting documentation.

Post-export compliance

Maintain records of the transaction, recipient, permitted research purpose, subsequent transfers and compliance with licence conditions.

Application documents

Depending on the applicable procedure, an application may require:

Description and classification of the biological material.

Scientific explanation of the research project.

Export contract or research collaboration agreement.

Foreign recipient's institutional details.

End-user certificate or equivalent assurances.

Information about the final destination.

Technical specifications and biological safety documentation.

Relevant sanitary or medical permissions.

Details of any intended onward transfer.

Article 22 of Federal Law No. 183-FZ establishes general requirements for applications, including accurate information about the exported subject and destination. It provides a general decision period of up to 45 days after receipt of the required application and documents, subject to applicable special rules.

Consultant Plus+1

 

7. Research Collaboration Agreements and Export Licensing

International biotechnology research agreements are important because they establish the legal conditions under which biological materials and research technologies are transferred.

A Russian research institution collaborating with a foreign university should address the following issues.

A. Permitted research purpose

The agreement should clearly identify whether the materials are being transferred for:

Genetic sequencing.

Vaccine research.

Drug discovery.

Microbiological analysis.

Cell research.

Agricultural biotechnology.

Clinical research.

B. Restrictions on onward transfer

Foreign research partners should not automatically receive unrestricted rights to transfer biological samples to other organisations.

The contract should establish whether additional consent and regulatory approval are required.

C. Intellectual property ownership

The parties should determine ownership and licensing arrangements concerning:

Research discoveries.

Patents.

Genetic engineering methods.

Biotechnology software.

Scientific publications.

Commercial research products.

D. Confidentiality and research data

The parties should establish appropriate safeguards for sensitive research information, personal data and commercially confidential material.

E. Regulatory compliance

The agreement should make the export conditional upon obtaining all necessary Russian and destination-country permissions.

Important: A research collaboration agreement does not replace a statutory export licence. Contractual consent cannot override Russian export-control legislation.

8. Important Judicial Decisions and Case Laws

Russian judicial decisions demonstrate that biotechnology exports can attract export-control requirements even when exporters claim that the materials are intended for medical or scientific research.

The following cases are particularly relevant.

Case 1. LLC StarExpert v. North-West Electronic Customs

Particularly important case

Case number: A56-36286/2023

Court: Arbitration Court of the North-Western District

Decision date: 12 March 2024

Subject: Export of frozen human biological materials to Hong Kong.

Facts:

LLC StarExpert exported frozen human oocytes for diagnostic research to a Hong Kong laboratory.

The company had obtained a permission document from Roszdravnadzor indicating a diagnostic purpose.

However, customs authorities subsequently examined the transaction and identified concerns about the actual purpose and potential onward use of the biological samples.

The foreign recipients could potentially use the samples themselves or transfer them to third parties.

The authorities concluded that the exporter had not sufficiently documented the intended use and that an additional export-control permission was necessary under Government Resolution No. 517 of 15 August 2005.

Legal issue:

Whether a medical or diagnostic export permission was sufficient to satisfy the separate requirements of Russian export-control legislation.

Judgment:

On 12 March 2024, the Arbitration Court of the North-Western District rejected StarExpert's cassation appeal and upheld the lower courts' decisions.

The company was held administratively responsible under Article 16.3 of the Russian Code of Administrative Offences.

Legal principle:

A permission issued by a medical regulatory authority does not automatically eliminate separate export-control obligations.

The exporter must establish the legitimate purpose and intended use of the biological materials and obtain any additional required permissions.

sudact.ru+1

Case 2. LLC StarExpert v. North-West Electronic Customs

Case number: A56-36289/2023

Court: Thirteenth Arbitration Court of Appeal

Decision date: 7 November 2023

Subject: Export of frozen human oocytes to Singapore.

Facts:

StarExpert exported frozen human reproductive biological materials to a fertility centre in Singapore.

The company claimed that the materials were intended for diagnostic investigations and relied on its regulatory documentation.

Customs authorities subsequently determined that the goods fell within the applicable dual-use export-control framework operating at the time of the transaction.

Legal issue:

Whether the exporter could rely on its medical documentation without separately satisfying export-control requirements.

Judgment:

The appellate court rejected the company's appeal and upheld the lower court's decision.

The company was found responsible under Article 16.3 of the Code of Administrative Offences.

Legal principle:

The description of biological materials as medical or diagnostic samples does not automatically exempt them from export-control obligations.

The exporter must establish compliance with all applicable legal requirements.

sudact.ru+1

Case 3. LLC StarExpert v. North-West Electronic Customs

Case number: A56-36290/2023

Decision date: 20 June 2024

Court: Arbitration Court of the North-Western District

Subject: Export-control identification and biological sample transfers.

Facts and legal issues:

The dispute concerned the export of human biological materials and the responsibility of the Russian exporter to identify potentially controlled products.

The case examined Article 19 and Article 24 of Federal Law No. 183-FZ.

Judicial significance:

The court emphasised that the Russian participant in foreign economic activity is responsible for identifying controlled goods and obtaining the necessary permissions.

Where necessary, the exporter can engage a specially authorised organisation to undertake identification.

The decision illustrates that the exporter cannot simply rely on the customs classification or the description of the material in its commercial documentation.

sudact.ru

Comparative analysis of the cases

Legal questionJudicial approach
Is medical permission sufficient?Not necessarily
Must the exporter identify controlled materials?Yes
Does research purpose automatically create an exemption?No
Can customs examine exports after release?Yes
Can third-party transfer risks matter?Yes
Is Article 16.3 relevant?Yes, where applicable export restrictions are breached

An important qualification: These cases concern human biological materials and the export-control framework applicable to their particular transactions. They should not be interpreted as establishing that every human sample, reproductive cell or research specimen requires an identical licence. Classification, intended use, applicable exemptions and the law in force on the transaction date remain decisive.

9. Administrative and Criminal Liability

Failure to comply with biotechnology export requirements can produce several forms of legal liability.

A. Administrative liability

Article 16.3 of the Russian Code of Administrative Offences addresses violations of applicable prohibitions and restrictions on the movement of goods across the EAEU customs border.

Depending on the circumstances, violations can result in administrative proceedings and penalties.

The StarExpert litigation demonstrates the practical importance of this provision.

B. Criminal liability

Article 189 of the Russian Criminal Code concerns unlawful export or transfer of goods, technologies, scientific and technical information, and other controlled items where the statutory elements of the offence are established.

Article 226.1 may also become relevant in cases involving unlawful movement of specified strategically important goods or other items covered by that provision.

Criminal liability is not automatic merely because a licensing document is missing. The applicable statutory elements, including the relevant conduct and other required circumstances, must be established.

C. Corporate and contractual consequences

Biotechnology exporters may additionally face:

Suspension or cancellation of export permissions.

Customs delays and seizure or detention where legally authorised.

Contractual disputes with foreign research partners.

Loss of commercial research opportunities.

Intellectual property disputes.

Reputational damage.

Regulatory investigations.

CIS Legislation+2

10. Fundamental Research and Scientific Publication Exemptions

An important feature of Russian export-control legislation is the distinction between fundamental scientific research and controlled technology transfers.

Under the explanatory provisions of Resolution No. 1287, export control does not extend to:

Publicly available information.

Fundamental scientific research.

Information necessary for preparing a patent application.

This distinction is important for international academic cooperation.

For example:

Publishing an ordinary scientific article about genetic research may fall outside export control.

Sharing publicly available scientific information is generally treated differently from transferring controlled technology.

Sending a controlled microorganism to a foreign laboratory may require licensing.

Providing specialised technical assistance concerning controlled biotechnology may also be regulated.

A university cannot automatically classify all its activities as fundamental research. The actual nature and purpose of the activity must be examined.

sudact.ru+1

11. International Legal Framework

Russian biotechnology research exports are also affected by international obligations.

A. Biological Weapons Convention (1972)

The Biological Weapons Convention prohibits the development, production, acquisition and retention of biological agents and toxins for prohibited purposes.

It also establishes obligations concerning the peaceful use of biological research.

B. United Nations Security Council Resolution 1540

Resolution 1540 requires states to adopt appropriate measures to prevent non-state actors from acquiring weapons of mass destruction and related materials.

C. Convention on Biological Diversity

The Convention on Biological Diversity is relevant to genetic resources, biodiversity protection and biotechnology governance.

D. Cartagena Protocol on Biosafety

The Cartagena Protocol on Biosafety addresses the safe handling, transfer and use of living modified organisms.

Its applicability depends on the particular organism, transaction and relevant treaty obligations.

These international frameworks complement, but do not replace, Russian domestic export licensing requirements.

12. Major Legal Challenges

Russian biotechnology research-export licensing faces several important challenges.

1. Classification difficulties

Biological materials can have multiple applications. A microorganism or genetic element may have legitimate medical uses but may also fall within a controlled category.

2. Research-purpose verification

Exporters must establish whether the declared scientific purpose is genuine and adequately documented.

3. International research collaboration

Different countries have different rules concerning biological samples, genetic information and biotechnology research.

4. Third-party transfers

Foreign recipients may transfer samples or technology to additional research institutions. This creates regulatory and contractual risks.

5. Digital biotechnology exports

Genetic datasets, specialised software and technical information can raise export-control questions even without physical shipment.

6. Regulatory fragmentation

Different government agencies may exercise jurisdiction over export control, medical regulation, sanitary safety, veterinary controls and customs enforcement.

7. Scientific innovation versus national security

Overly broad controls may restrict legitimate international research, while inadequate controls may create biological security risks.

13. Recommendations for Biotechnology Companies and Research Institutions

Russian biotechnology exporters should establish a comprehensive internal export-compliance programme.

The programme should include:

Classification of biological materials before shipment.

Independent assessment of controlled technologies.

Verification of foreign recipients.

Documentation of research purposes.

Appropriate end-user commitments.

Restrictions on unauthorised onward transfers.

Verification of applicable sanctions and destination-country restrictions.

Separate review of physical samples and electronic technology transfers.

Regular compliance training for researchers and administrative personnel.

Retention of licences, contracts and customs records.

Research agreements should also clearly allocate responsibility for obtaining regulatory permissions.

These measures reduce the possibility of administrative penalties, customs disputes and criminal investigations.

14. Critical Legal Analysis

The Russian biotechnology research-export licensing framework demonstrates an attempt to balance scientific progress with national security.

Federal Law No. 183-FZ establishes the general legal foundation, while Resolution No. 1287 provides detailed biological export-control classifications.

Resolution No. 572 addresses another category of pathogenic microorganism movements, creating a separate regulatory route for materials outside the controlled list.

The StarExpert litigation provides particularly valuable judicial guidance.

It demonstrates three important principles:

Regulatory permission for medical purposes does not necessarily satisfy export-control requirements.

The exporter bears responsibility for identifying controlled biological materials.

Customs authorities may investigate transactions after goods have already been released.

Nevertheless, the legal system must distinguish genuinely dangerous dual-use transfers from legitimate scientific cooperation. Excessive restrictions could discourage international scientific collaboration and limit access to research partnerships.

A more predictable classification process, transparent licensing decisions and effective inter-agency coordination would improve the balance between scientific freedom and biological security.

15. Conclusion

Biotechnology Research-Export Licensing in Russia is governed by a combination of export-control legislation, biological safety rules, customs regulations and international obligations.

Federal Law No. 183-FZ is the principal statutory foundation. Government Resolution No. 1287 identifies controlled microorganisms, toxins, genetic elements, equipment, technologies and software. Government Resolution No. 572 provides a separate regulatory framework for certain pathogenic microorganisms and viruses.

The StarExpert decisions of 2023 and 2024 demonstrate that biological research exports require careful legal classification and that medical or diagnostic permissions cannot automatically replace export-control authorisations.

Ultimately, the Russian regulatory framework seeks to ensure that biotechnology research can participate in international scientific cooperation without compromising national security, public health and biological safety.

16. Important Legal Provisions and Research References

Legal instrumentRelevance
Federal Law No. 183-FZ (1999)General export-control framework
Article 19, Law No. 183-FZLicensing of controlled exports
Article 22, Law No. 183-FZLicensing application and decisions
Article 24, Law No. 183-FZIdentification responsibilities
Government Resolution No. 1287 (2022)Controlled biological materials and technologies
Government Resolution No. 572 (2022)Pathogenic microorganism movements
Government Resolution No. 517 (2005)Special export-control procedures
Code of Administrative Offences, Article 16.3Customs restrictions violations
Criminal Code, Article 189Unlawful export or transfer of controlled items

Primary legal and judicial sources

Federal Law No. 183-FZ – On Export Control.

Government Resolution No. 1287 of 16 July 2022.

Government Resolution No. 572 of 2 April 2022.

Article 22 – General licensing requirements.

StarExpert – Case No. A56-36286/2023, 12 March 2024.

StarExpert – Case No. A56-36289/2023, 7 November 2023.

Case No. A56-36290/2023, 20 June 2024.

Legal research note: This is an academic overview, not an individual export authorisation or legal opinion. The cited court decisions concern particular transactions and the legislation applicable at the relevant time. Before an actual export, the current consolidated legislation, controlled lists, sanctions and licensing procedures should be checked.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT